Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

11:20am, Monday, 07'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for IBB
As COVID-19 cases continue to decline and COVID restrictions are lifted, the U.S. is returning to a sense of normalcy. This has many thinking if additional booster shots will be necessary.

This 1 Innovation Could Disrupt Pfizer and Moderna's Vaccine Supremacy

03:37pm, Saturday, 05'th Mar 2022 The Motley Fool
Intranasal sprays might be more effective than jabs.
Intranasal sprays might be more effective than jabs.

3 Top Growth Stocks to Buy Right Now

11:00am, Saturday, 05'th Mar 2022 The Motley Fool
And you can pick them up at a discount.

Is Moderna Stock a Buy Now?

04:00pm, Friday, 04'th Mar 2022 The Motley Fool
Although the company beat earnings, questions about its future remain.

Is Moderna Stock a Buy Now?

04:00pm, Friday, 04'th Mar 2022 The Motley Fool
Although the company beat earnings, questions about its future remain.
Moderna is heading for a clash with the South African government and the World Health Organization over patent claims that vaccine advocates say could threaten the continent’s access to Covid-19 shots.

Better Post-Earnings Buy: Moderna or Novavax?

11:00am, Friday, 04'th Mar 2022 The Motley Fool
Both companies are predicting billions of dollars in vaccine revenue.
The EU regulator’s vaccines chief Dr Marco Cavaleri said the Moderna vaccine for younger children will be a half-dose of what is given to older teens and adults.

Pfizer, Moderna project $51 billion in combined vaccine sales this year

05:57am, Friday, 04'th Mar 2022 Bitcoin Ethereum News
The post Pfizer, Moderna project $51 billion in combined vaccine sales this year appeared on BitcoinEthereumNews.com . Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Dado Ruvic | Reuters Pfizer and Moderna expect $51 billion…
Dr. Fauci would not be specific about which technologies will be included and could not say if Moderna’s powerful coronavirus vaccine — developed in partnership with N.I.H. scientists — would be among them, he said.

Why Moderna and BioNTech Tumbled on Thursday

10:58pm, Thursday, 03'rd Mar 2022 The Motley Fool
Investors were spooked by the government''s plan to share certain COVID treatment technologies with international health organizations.
Dr. Fauci would not be specific about which technologies will be included and could not say if Moderna’s powerful coronavirus vaccine — developed in partnership with N.I.H. scientists — would be among them, he said.
Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, seasonal virus.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE